Status:

COMPLETED

Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients

Lead Sponsor:

Sun Yat-sen University

Collaborating Sponsors:

Eli Lilly and Company

Amylin Pharmaceuticals, LLC.

Conditions:

Diabetes Mellitus, Type 2

Newly Diagnosed

Eligibility:

All Genders

30-70 years

Phase:

NA

Brief Summary

The purpose of this study is to investigate and evaluate the effects of different interventions (1. exenatide, 2. insulin, 3. thiazolidinedione) on glycemic control and β-cell function in newly diagno...

Detailed Description

One of the fundamental defects in type 2 diabetes mellitus is declining β-cell function. Exenatide targets multiple metabolic disturbances in type 2 diabetes and exerts direct effects on β-cell, which...

Eligibility Criteria

Inclusion

  • newly-diagnosed type 2 diabetic patients, drug naïve
  • age 30\~70 years
  • HbA1c 7.0\~10.0%
  • BMI 20\~35 kg/m2, stable body weight (≤10% variation) for at least 3 months prior to screening
  • female patients of reproductive age should practice a reliable method of birth control throughout the study

Exclusion

  • acute or severe chronic diabetic complications
  • congestive heart failure (NYHA grade Ⅲ\~Ⅳ)
  • severe gastrointestinal disease
  • severe osteoporosis or history of pathological fracture,or use of bisphosphonates preparation
  • other severe intercurrent illness
  • serum aminotransferase (ALT and AST) level higher than 2 times of the upper normal limits and/or serum creatinie≥133µmol/L (1.5mg/dL)
  • tested positive for glutamic acid decarboxylase antibody
  • use of weight loss drugs, corticosteroids, drugs known to affect gastrointestinal motility, transplantation medications, or any investigational drug
  • history of pancreatitis
  • serum triglyceride ≥ 5.0 mmol/L
  • pregnancy

Key Trial Info

Start Date :

August 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2012

Estimated Enrollment :

416 Patients enrolled

Trial Details

Trial ID

NCT01147627

Start Date

August 1 2010

End Date

December 1 2012

Last Update

August 21 2013

Active Locations (25)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 7 (25 locations)

1

China-Japan Friendship Hospital

Beijing, Beijing Municipality, China, 100029

2

Peking University People's Hospital

Beijing, Beijing Municipality, China, 100044

3

Beijing Hospital

Beijing, Beijing Municipality, China, 100730

4

Chinese PLA General Hospital

Beijing, Beijing Municipality, China, 100853